KEMPHARM, INC Business Finance Contracts & Agreements

82 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement between Zevra Therapeutics, Inc. and Buyer (February 26, 2025)
Purchase Agreements
KEMPHARM, INC
Pharmaceuticals
DE
2025
Description of Zevra Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
KEMPHARM, INC
Pharmaceuticals
2025
Zevra Therapeutics, Inc. Underwriting Agreement for Common Stock Offering with Cantor Fitzgerald & Co. and William Blair & Company, L.L.C.
Underwriting Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2024
Equity Distribution Agreement between Zevra Therapeutics, Inc. and Citizens JMP Securities, LLC (July 12, 2024)
Equity Distribution Agreements
KEMPHARM, INC
Pharmaceuticals
DE
2024
Credit Agreement among Zevra Therapeutics, Inc., Subsidiary Guarantors, Alter Domus (US) LLC, and Lenders (April 5, 2024)
Credit Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2024
Description of Zevra Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
KEMPHARM, INC
Pharmaceuticals
2024
Common Stock Purchase Warrant Agreement between Zevra Therapeutics, Inc. and Armistice Capital Master Fund Ltd.
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2023
Loan Purchase Agreement between Zevra Therapeutics, Inc. and Nantahala Capital Management, LLC and Affiliates
Loan Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2023
Bridge Loan Agreement between Acer Therapeutics Inc. and Zevra Therapeutics, Inc. dated August 30, 2023
Loan Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2023
Description of Zevra Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
KEMPHARM, INC
Pharmaceuticals
2023
Revolving Loan Agreement between KemPharm, Inc. and Ameris Bank dated May 31, 2022
Loan Agreements
KEMPHARM, INC
Pharmaceuticals
FL
2022
Asset Purchase Agreement between Orphazyme A/S (in restructuring) and KemPharm Denmark A/S, Guaranteed by KemPharm Inc.
Purchase Agreements
KEMPHARM, INC
Pharmaceuticals
2022
Description of KemPharm, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
KEMPHARM, INC
Pharmaceuticals
2022
KemPharm, Inc. 2021 Employee Stock Purchase Plan
Stock Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2021
KemPharm, Inc. $75,000,000 Equity Distribution Agreement with JMP Securities LLC and RBC Capital Markets, LLC
Equity Distribution Agreements
KEMPHARM, INC
Pharmaceuticals
DE
2021
KemPharm, Inc. Reload Offer Letter Agreement for Common Stock Purchase Warrants (June 2021)
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
2021
Series D Common Stock Purchase Warrant Agreement between KemPharm, Inc. and Holder
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2021
Description of KemPharm, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
KEMPHARM, INC
Pharmaceuticals
2021
Specimen stock certificate evidencing shares of Common Stock
Stock Agreements
KEMPHARM, INC
Pharmaceuticals
2021
KemPharm, Inc. Reload Offer Letter Agreement for Common Stock Purchase Warrants (January 2021)
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
2021
Series C Common Stock Purchase Warrant Agreement between KemPharm, Inc. and Holder
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2021
Series A Common Stock Purchase Warrant Agreement between KemPharm, Inc. and Roth Capital Partners, LLC
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2021
KemPharm, Inc. Common Stock Purchase Warrant Agreement (January 2021)
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2021
KemPharm, Inc. Underwriting Agreement with Roth Capital Partners, LLC (2021)
Underwriting Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2021
Series B Pre-Funded Common Stock Purchase Warrant between KemPharm, Inc. and Holder
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020
Series A Common Stock Purchase Warrant Agreement between KemPharm, Inc. and Holder
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020
Underwriting Agreement between KemPharm, Inc. and Roth Capital Partners, LLC (2020)
Underwriting Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020
Description of KemPharm, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
KEMPHARM, INC
Pharmaceuticals
2020
KemPharm, Inc. and Lincoln Park Capital Fund, LLC Common Stock Purchase Agreement (February 2020)
Purchase Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020
First Amendment to Bridge Loan Agreement between Acer Therapeutics Inc. and Zevra Therapeutics, Inc.
Modification Agreements
KEMPHARM, INC
Pharmaceuticals
2024
Registration Rights Agreement between Zevra Therapeutics, Inc. and Sellers (August 30, 2023)
Registration Rights Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2023
Note Purchase Agreement between Zevra Therapeutics, Inc. and Nantahala Capital Management, LLC et al.
Note Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2023
KemPharm, Inc. Payoff and Termination Agreement with Deerfield Lenders (February 2021)
Facility Agreements
KEMPHARM, INC
Pharmaceuticals
2021
Amendment to Senior Secured Convertible Notes and Warrant by KemPharm, Inc. and Note Holders
Modification Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2021
Joinder Agreement to December 2020 Exchange Agreement among KemPharm, Inc. and Lenders
Joinder Agreements
KEMPHARM, INC
Pharmaceuticals
2020
Joinder Agreement to December 2020 Exchange Agreement Among KemPharm, Inc. and Lenders
Joinder Agreements
KEMPHARM, INC
Pharmaceuticals
2020
Amendment to Facility Agreement, Notes, and December 2020 Exchange Agreement by and among KemPharm, Inc. and Deerfield Lenders (December 24, 2020)
Facility Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020
December 2020 Exchange Agreement and Amendment to Facility Agreement, Notes, and Investors’ Rights Agreement by and among KemPharm, Inc. and Deerfield Lenders
Exchange Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020
Amendment to Senior Secured Convertible Notes and Warrant by KemPharm, Inc. and Lenders
Modification Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020
Registration Rights Agreement between KemPharm, Inc. and Lincoln Park Capital Fund, LLC (February 17, 2020)
Registration Rights Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020